How Do I Enter My Baseline Metrics in the Calibrate App?

At a glance
- App section / follow the on-screen baseline prompts in the current Calibrate app
- Intake / complete the Comprehensive Health Intake form during setup
- Current lab windows / CMP within 3 months; HbA1c, lipid panel, and TSH within 6 months of the clinical visit
- Timing / Calibrate says required labs should be completed at least 5 business days before the clinical appointment
- Sync options / Withings scale through Apple Health or Google Fit, according to Calibrate's current setup guide
- Initial trackers / Weight and Energy Level; Sleep and Steps are also displayed in the program
- BMI threshold for GLP-1 eligibility / BMI ≥30, or BMI ≥27 with a weight-related condition
- Clinical use / the clinician reviews health history and lab results when creating the treatment plan
Why Baseline Metrics Matter Before You Start a GLP-1 Program
Your baseline data is the clinical starting line. Without accurate numbers on day one, your care team may be unable to confirm medication eligibility, identify contraindications, or measure progress against a reliable starting point.
The FDA-approved label for semaglutide 2.4 mg (Wegovy) specifies adult patients with a BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia. [1] Confirming that threshold is the first thing your metrics accomplish.
What Baseline Data Can and Cannot Tell You
Baseline measurements document the starting point for later comparison; they do not predict that a particular medication will work. The STEP 1 trial recorded anthropometric and laboratory baselines before randomization, but its 14.9% mean weight-loss result at 68 weeks cannot be used to claim that entering more app data causes better outcomes [2].
Calibrate's current help center, not an AACE guideline, defines the program's present lab requirements. It lists a comprehensive metabolic panel collected within 3 months of the clinical visit and HbA1c, lipid panel, and TSH collected within 6 months. Program requirements can change, so the app and Calibrate's current instructions control [25].
Clinical Significance of Each Metric
Each number your care team requests ties directly to a prescribing or safety decision.
HbA1c helps identify prediabetes or diabetes, while a metabolic panel provides information about kidney function, electrolytes, glucose, and liver-associated enzymes. A lipid panel and blood-pressure measurement contribute to cardiovascular-risk assessment. These results inform clinical evaluation, but they do not automatically determine a GLP-1 dose; dosing and escalation follow the selected product's label and the prescriber's assessment.
Step-by-Step: Entering Your Baseline Metrics in the Calibrate App
Calibrate's current FAQ says the app provides on-screen instructions for each baseline metric. The exact labels and order can change, so follow the prompts shown in your account [26].
Step 1. Download and Log In
Download the Calibrate app from the Apple App Store or Google Play Store and sign in with the account used for enrollment. Calibrate directs members to complete app setup and the Comprehensive Health Intake form before the clinical visit [27]. If the baseline prompt is missing, use the Support channel rather than relying on an old screen name.
Step 2. Enter Anthropometric Measurements
Enter only the measurements requested in the current app. These commonly include:
- Height (feet/inches or centimeters)
- Current body weight (pounds or kilograms, measured first thing in the morning, after using the bathroom, without shoes)
- Waist circumference (measured at the level of the umbilicus, not the narrowest point)
Waist circumference can add information about abdominal adiposity beyond BMI. Use Calibrate's current Waist Measurement Guide because measuring at a different anatomical site can materially change the result [26].
Weigh yourself on the same scale each time, ideally a digital scale accurate to 0.1 lb. Inconsistent equipment introduces noise into your progress tracking.
Step 3. Enter Blood Pressure and Heart Rate
If the app or clinician requests blood pressure, use a validated upper-arm cuff and follow CDC measurement guidance: avoid exercise, caffeine, and smoking for 30 minutes beforehand; sit quietly for 5 minutes; keep the arm supported at chest height; and take at least two readings 1 to 2 minutes apart [22].
Heart rate above 100 bpm at rest may flag sinus tachycardia, which is relevant because GLP-1 receptor agonists are associated with a mean heart rate increase of approximately 1 to 4 bpm in clinical trials. [8] Your provider may order additional cardiac evaluation if baseline resting heart rate is elevated.
Step 4. Upload or Manually Enter Lab Values
This is the step most users skip or delay, and it is the one most likely to slow down your first prescription.
Calibrate currently allows qualifying recent results to be uploaded during Orientation or attached to a Support message. Its upload FAQ accepts photos or PDFs and explains the exact current taps. If existing results do not meet the required tests or collection windows, Calibrate says it will issue a new lab order [28].
Calibrate's current published requirements include:
- Comprehensive metabolic panel collected within 3 months of the clinical visit
- HbA1c collected within 6 months
- Lipid panel collected within 6 months
- TSH collected within 6 months
HbA1c helps classify glycemic status, but a normal result does not by itself establish that a GLP-1 medicine is safe or appropriate. The clinician must still review the selected drug's contraindications, warnings, current medications, symptoms, and other relevant history.
Step 5. Complete the Health History Questionnaire
After biometrics and labs, the app presents a structured questionnaire covering:
- Current medications (critical for drug interaction screening)
- Personal or family history of medullary thyroid carcinoma or MEN2, which are contraindications in current Wegovy and Zepbound labeling [21,17]
- Family history of medullary thyroid carcinoma
- Gastrointestinal history, including severe gastroparesis, because current labeling contains important warnings and use limitations
- Mental health history, because mood changes or suicidal thoughts should be discussed with a clinician even though FDA's later review did not identify an increased suicidal-ideation or suicidal-behavior risk for GLP-1 receptor agonists [9]
Answer every question. Skipping a contraindication screen does not make the contraindication disappear; it means your physician prescribes without complete information.
Step 6. Sync a Wearable or Health App (Optional but Recommended)
Calibrate's current setup guide directs members to connect through Apple Health or Google Fit and to set up the supplied Withings smart scale [27]. Its tracking FAQ says Weight and Energy Level are the two required trackers at the beginning, while Sleep and Steps also appear in the program [29].
Self-weighing evidence is mixed by population and program design, but a systematic review found regular self-weighing was generally associated with more weight loss and was not linked to worse psychological outcomes in the reviewed adult weight-management studies. [10] If your app account supports smart-scale syncing, it can reduce manual entry errors.
Step 7. Confirm Submission and Review With Your Provider
Complete every field the app marks as required and retain the original lab report so dates, units, and reference ranges can be checked. Calibrate says members should finish setup, record baseline measurements, and complete required labs at least 5 business days before the clinical appointment [27]. If the app does not confirm completion, contact Support in the app.
Common Errors to Avoid When Entering Baseline Metrics
Entering Weight at the Wrong Time of Day
Body weight fluctuates by 1 to 3 kg across a single day depending on food intake, hydration, and bowel habits. [11] Enter your weight first thing in the morning, after voiding, before eating or drinking. This matches the protocol used in clinical trials like STEP-1 and SURMOUNT-1, making your data comparable to the evidence base your physician references.
Using a Waist Measurement From Clothing Labels
Clothing waist sizes are vanity measurements. Pant waist sizes in U.S. Retail commonly run 1 to 2 inches smaller than actual anatomical circumference. Measure with a flexible tape measure placed directly on skin at the level of the navel, parallel to the floor, at the end of a normal exhale.
Uploading Labs Outside Calibrate's Current Windows
Calibrate currently requires the CMP within 3 months and HbA1c, lipid panel, and TSH within 6 months of the clinical visit [25]. A result outside those windows may still be useful medical history, but it may not satisfy onboarding. Check the collection date, not merely the date the portal displayed the result.
Omitting Medications
Many users forget to list over-the-counter supplements, particularly those containing stimulants (synephrine, high-dose caffeine) or those that affect thyroid function (biotin at doses above 5 mg/day can falsely lower TSH readings). [12] List every substance, prescribed or not.
What Happens to Your Baseline Data After Submission
Provider Review and Dose Selection
Calibrate states that the clinician reviews the health history and lab results during the clinical visit and uses them to create a treatment plan [27]. That review addresses:
- Whether you meet FDA eligibility criteria for semaglutide (Wegovy) or, where available, tirzepatide (Zepbound)
- Which medication, if any, is appropriate and covered or otherwise accessible
- Any pre-treatment interventions needed (e.g., blood pressure control before GLP-1 initiation)
Starting doses and escalation schedules come from the selected medication's prescribing information and clinical judgment; app metrics do not create a custom starting rung outside the label. SURMOUNT-1 reported mean outcomes for randomized groups and does not predict an individual member's result [13].
Tracking Progress Against Baseline
Every metric entered at the start becomes a reference point for later tracking. Follow the cadence displayed in the current app rather than assuming a fixed 4-, 12-, 24-, or 52-week medical-visit schedule.
A weight loss of less than 5% of initial body weight after 12 to 16 weeks on a stable dose is generally considered an inadequate response per AACE guidelines, and may prompt a dose increase or medication switch. [3] That judgment is only possible if the starting point is documented accurately.
How Baseline Metrics Connect to Your Four-Pillar Program
Calibrate structures its program around four domains: medication, food, sleep, and exercise. Each baseline metric feeds at least one of those pillars.
The table below maps each baseline metric to its clinical purpose and the program pillar it informs.
| Metric | Clinical Purpose | Program Pillar |
|---|---|---|
| Body weight and BMI | GLP-1 eligibility, dose selection, progress tracking | Medication, Food |
| Waist circumference | Visceral adiposity and cardiometabolic risk | Food, Exercise |
| Fasting glucose and HbA1c | Diabetes screening, GLP-1 safety | Medication |
| Lipid panel | Cardiovascular risk stratification | Food, Medication |
| Blood pressure | Cardiovascular risk, titration pace | Medication, Exercise |
| Resting heart rate | Baseline cardiac function, GLP-1 monitoring | Medication, Exercise |
| TSH | Rule out hypothyroidism as weight-gain driver | Medication |
| Liver enzymes (ALT/AST) | NAFLD screening, titration safety | Food |
| Sleep duration (from wearable) | Sleep disorder screening, metabolic impact | Sleep |
| Step count (from wearable) | Physical activity baseline | Exercise |
Poor sleep is not just a wellness concern. Adults sleeping fewer than 6 hours per night show measurable dysregulation of ghrelin and leptin, the appetite-regulating hormones that GLP-1 agonists also target. A 2022 review in the Journal of Clinical Endocrinology and Metabolism found that sleep restriction increased ad libitum caloric intake by approximately 300 kcal/day in controlled conditions. [15] Your sleep baseline tells the coaching team where behavioral support is needed most.
Troubleshooting: If the App Will Not Accept Your Data
App Shows an Error When You Try to Save Weight
Confirm that the number and unit match the scale reading and that the Withings scale is syncing through Apple Health or Google Fit as directed in the current setup guide [27]. If the value still will not save, use Calibrate's Support channel; do not enter a different number simply to bypass validation.
Lab Upload Is Rejected
Calibrate's current upload FAQ allows qualifying lab results to be sent as photos or PDFs during Orientation or attached to a Support message. Follow its current file and attachment instructions, and ensure the patient's name, collection date, result, unit, and laboratory reference range are legible [28].
You Do Not Have Recent Labs
Use the in-app Support channel. Calibrate says it will issue a lab order when qualifying recent results are unavailable; turnaround depends on the order, collection site, and test processing [28]. Never estimate or invent a lab value.
Wearable Sync Is Not Working
Check the current Calibrate setup guide and the permissions shown in Apple Health or Google Fit. Grant only the data access needed for the trackers you intend to use. If syncing still fails, contact Calibrate Support because mobile operating-system menus change over time [27].
Baseline Metrics at Follow-Up Visits: What Repeats and When
Baseline entry is followed by ongoing tracking. Calibrate's current tracking FAQ identifies Weight and Energy Level as the initial required trackers and shows Sleep and Steps as additional trackers [29]. Follow the cadence in the current app.
Regular self-weighing can support weight-management programs for some adults, and a systematic review found it was generally associated with greater weight loss [16]. Use a frequency that matches the program and does not worsen anxiety or disordered-eating symptoms.
HbA1c is typically repeated at 3 months and 6 months for patients with prediabetes or diabetes, consistent with the American Diabetes Association's 2024 Standards of Care recommendation for quarterly HbA1c assessment in patients on pharmacological treatment. [4]
Blood pressure should be re-entered at every visit if you have a baseline reading above 130/80 mmHg. Semaglutide reduces systolic blood pressure by a mean of 3 to 6 mmHg in patients with obesity, a clinically meaningful effect documented in the STEP-1 trial. [2]
Frequently asked questions
How do I enter my baseline metrics in the Calibrate app?
What metrics does Calibrate require before my first visit?
Can I sync a smart scale with the Calibrate app?
What labs do I need before starting a Calibrate program?
What if I do not have recent lab results when I sign up?
How often do I need to update my metrics in the Calibrate app?
Does Calibrate use my baseline metrics to select my GLP-1 dose?
What is the BMI requirement to qualify for a GLP-1 through Calibrate?
Can I manually enter lab values instead of uploading a document?
What happens if my baseline blood pressure is too high for a GLP-1?
Why does Calibrate ask for waist circumference, not just weight?
References
- U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183
- Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Framework for Obesity Care. Endocr Pract. 2023. https://www.endocrine.org/clinical-practice-guidelines
- American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1). https://diabetesjournals.org/care/issue/47/Supplement_1
- Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. https://pubmed.ncbi.nlm.nih.gov/26707365/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- National Heart, Lung, and Blood Institute. Classification of Overweight and Obesity by BMI, Waist Circumference, and Associated Disease Risks. NIH Publication No. 98-4083. https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi_dis.htm
- Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Mol Metab. 2021;46:101102. https://pubmed.ncbi.nlm.nih.gov/33068776/
- U.S. Food and Drug Administration. FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications. Drug Safety Communication. 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp
- Steinberg DM, Tate DF, Bennett GG, Ennett S, Samuel-Hodge C, Ward DS. Daily self-weighing and adverse psychological outcomes: a randomized controlled trial. Am J Prev Med. 2014;46(1):24-29. https://pubmed.ncbi.nlm.nih.gov/24355668/
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription medications to treat overweight and obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
- U.S. Food and Drug Administration. Testing for Biotin Interference in In Vitro Diagnostic Devices. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/testing-biotin-interference-in-vitro-diagnostic-devices
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/10.1056/NEJMoa2206038
- U.S. Department of Health and Human Services. 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. Federal Register. 2020. https://www.federalregister.gov/documents/2020/05/01/2020-07419/21st-century-cures-act-interoperability-information-blocking-and-the-onc-health-it-certification
- Hibi M, Kubota C, Mizuno T, et al. Effect of shortened sleep on energy expenditure, core body temperature, and appetite: a human randomised crossover trial. Sci Rep. 2017;7:39640. https://pubmed.ncbi.nlm.nih.gov/28071649/
- Zheng Y, Klem ML, Sereika SM, Danford CA, Ewing LJ, Burke LE. Self-weighing in weight management: a systematic literature review. Obesity (Silver Spring). 2015;23(2):256-265. https://pubmed.ncbi.nlm.nih.gov/25521523/
- U.S. Food and Drug Administration. Zepbound prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
- U.S. Preventive Services Task Force. Weight loss to prevent obesity-related morbidity and mortality in adults: behavioral interventions. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions
- Centers for Disease Control and Prevention. Adult BMI categories. https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes. Diabetes Care. https://diabetesjournals.org/care/issue
- U.S. Food and Drug Administration. Wegovy prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s015lbl.pdf
- Centers for Disease Control and Prevention. Measuring blood pressure. https://www.cdc.gov/high-blood-pressure/measure/index.html
- Centers for Disease Control and Prevention. Prediabetes: A1C Test. https://www.cdc.gov/diabetes/diabetes-testing/prediabetes-a1c-test.html
- U.S. Food and Drug Administration. Testing for Biotin Interference in In Vitro Diagnostic Devices. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/testing-biotin-interference-in-vitro-diagnostic-devices
- Calibrate. Why do I need to complete another set of labs if I already had my labs done? https://www.joincalibrate.com/faqs/why-do-i-need-to-complete-another-set-of-labs-if-i
- Calibrate. How do I enter my baseline metrics in the Calibrate app? https://www.joincalibrate.com/faqs/how-do-i-enter-my-baseline-metrics-in-the-calibrate-app
- Calibrate. What are the requirements and what can I expect for my clinical appointment? https://www.joincalibrate.com/faqs/what-are-the-requirements-and-what-can-i-expect-for-my-doctor-appointment
- Calibrate. How do I upload recent lab results to the Calibrate app? https://www.joincalibrate.com/faqs/how-do-i-upload-recent-lab-results-to-the-calibrate
- Calibrate. When do I start tracking in the Calibrate app? https://www.joincalibrate.com/faqs/when-do-i-start-tracking-in-the-calibrate-app